Global celiac diseases drugs market 2024-2028

PUBLISHED: June 11, 2024

PAGES: 162 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The celiac diseases drugs market is forecasted to grow by USD 1101.1 mn during 2023-2028, accelerating at a CAGR of 21.21% during the forecast period. The report on the celiac diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac diseases, and government initiatives.

Technavio's celiac diseases drugs market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	17.22%
CAGR	21.21%
Incremental Value	$1101.1mn

By Therapy

First line treatment
Second-line treatment

By Route Of Administration

Oral
Parenteral

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth during the next few years. Also, increasing promising developments in celiac treatment and rising prevalence and diagnosis will lead to sizable demand in the market.

The report on the celiac diseases drugs market covers the following areas:

Celiac diseases drugs market sizing
Celiac diseases drugs market forecast
Celiac diseases drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading celiac diseases drugs market vendors that include 9 Meters Biopharma Inc, Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Artielle Immunotherapeutics Inc, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech BV, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ImmunogenX Inc., Johnson and Johnson Services Inc., Precigen Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, and Zedira GmbH. Also, the celiac diseases drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45214

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Celiac Diseases Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2018 - 2022 ($ million)
4.2 Therapy segment analysis 2018 - 2022
- Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.3 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy

6.1 Market segments
- Chart on Therapy - Market share 2023-2028 (%)
- Data Table on Therapy - Market share 2023-2028 (%)
6.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
6.3 First line treatment - Market size and forecast 2023-2028
- Chart on First line treatment - Market size and forecast 2023-2028 ($ million)
- Data Table on First line treatment - Market size and forecast 2023-2028 ($ million)
- Chart on First line treatment - Year-over-year growth 2023-2028 (%)
- Data Table on First line treatment - Year-over-year growth 2023-2028 (%)
6.4 Second-line treatment - Market size and forecast 2023-2028
- Chart on Second-line treatment - Market size and forecast 2023-2028 ($ million)
- Data Table on Second-line treatment - Market size and forecast 2023-2028 ($ million)
- Chart on Second-line treatment - Year-over-year growth 2023-2028 (%)
- Data Table on Second-line treatment - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
- Data Table on Market opportunity by Therapy ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Parenteral - Market size and forecast 2023-2028
- Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
- Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
- Chart on Parenteral - Year-over-year growth 2023-2028 (%)
- Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Adaptive Biotechnologies Corp.
- Adaptive Biotechnologies Corp. - Overview
- Adaptive Biotechnologies Corp. - Product / Service
- Adaptive Biotechnologies Corp. - Key news
- Adaptive Biotechnologies Corp. - Key offerings
12.4 Almirall SA
- Almirall SA - Overview
- Almirall SA - Product / Service
- Almirall SA - Key news
- Almirall SA - Key offerings
12.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
12.6 AMYRA Biotech AG
- AMYRA Biotech AG - Overview
- AMYRA Biotech AG - Product / Service
- AMYRA Biotech AG - Key offerings
12.7 BioLineRx Ltd.
- BioLineRx Ltd. - Overview
- BioLineRx Ltd. - Product / Service
- BioLineRx Ltd. - Key offerings
12.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
12.9 Calypso Biotech BV
- Calypso Biotech BV - Overview
- Calypso Biotech BV - Product / Service
- Calypso Biotech BV - Key offerings
12.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.11 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 ImmunogenX Inc.
- ImmunogenX Inc. - Overview
- ImmunogenX Inc. - Product / Service
- ImmunogenX Inc. - Key offerings
12.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
12.14 Precigen Inc.
- Precigen Inc. - Overview
- Precigen Inc. - Key offerings
12.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR45214

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Therapy - Market share 2023-2028 (%)
Exhibits33: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Therapy
Exhibits35: Data Table on Comparison by Therapy
Exhibits36: Chart on First line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on First line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on First line treatment - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on First line treatment - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Second-line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Second-line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Second-line treatment - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Second-line treatment - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Therapy ($ million)
Exhibits45: Data Table on Market opportunity by Therapy ($ million)
Exhibits46: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits47: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Route of Administration
Exhibits49: Data Table on Comparison by Route of Administration
Exhibits50: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Route of Administration ($ million)
Exhibits59: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2023-2028 (%)
Exhibits62: Data Table on Market share by geography 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Data Tables on Market opportunity by geography ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Adaptive Biotechnologies Corp. - Overview
Exhibits110: Adaptive Biotechnologies Corp. - Product / Service
Exhibits111: Adaptive Biotechnologies Corp. - Key news
Exhibits112: Adaptive Biotechnologies Corp. - Key offerings
Exhibits113: Almirall SA - Overview
Exhibits114: Almirall SA - Product / Service
Exhibits115: Almirall SA - Key news
Exhibits116: Almirall SA - Key offerings
Exhibits117: Amgen Inc. - Overview
Exhibits118: Amgen Inc. - Product / Service
Exhibits119: Amgen Inc. - Key news
Exhibits120: Amgen Inc. - Key offerings
Exhibits121: AMYRA Biotech AG - Overview
Exhibits122: AMYRA Biotech AG - Product / Service
Exhibits123: AMYRA Biotech AG - Key offerings
Exhibits124: BioLineRx Ltd. - Overview
Exhibits125: BioLineRx Ltd. - Product / Service
Exhibits126: BioLineRx Ltd. - Key offerings
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key news
Exhibits130: Bristol Myers Squibb Co. - Key offerings
Exhibits131: Calypso Biotech BV - Overview
Exhibits132: Calypso Biotech BV - Product / Service
Exhibits133: Calypso Biotech BV - Key offerings
Exhibits134: GlaxoSmithKline Plc - Overview
Exhibits135: GlaxoSmithKline Plc - Business segments
Exhibits136: GlaxoSmithKline Plc - Key news
Exhibits137: GlaxoSmithKline Plc - Key offerings
Exhibits138: GlaxoSmithKline Plc - Segment focus
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: ImmunogenX Inc. - Overview
Exhibits143: ImmunogenX Inc. - Product / Service
Exhibits144: ImmunogenX Inc. - Key offerings
Exhibits145: Johnson and Johnson Services Inc. - Overview
Exhibits146: Johnson and Johnson Services Inc. - Business segments
Exhibits147: Johnson and Johnson Services Inc. - Key news
Exhibits148: Johnson and Johnson Services Inc. - Key offerings
Exhibits149: Johnson and Johnson Services Inc. - Segment focus
Exhibits150: Precigen Inc. - Overview
Exhibits151: Precigen Inc. - Key offerings
Exhibits152: Sanofi SA - Overview
Exhibits153: Sanofi SA - Business segments
Exhibits154: Sanofi SA - Key news
Exhibits155: Sanofi SA - Key offerings
Exhibits156: Sanofi SA - Segment focus
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits162: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits164: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Information sources
Exhibits171: Data validation
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Data synthesis
Exhibits174: 360 degree market analysis
Exhibits175: List of abbreviations